{"name":"Solid Biosciences","slug":"solid-bio","ticker":"SLDB","exchange":"NASDAQ","domain":"solidbio.com","description":"Solid Biosciences is a biopharmaceutical company focused on developing gene therapies for rare neuromuscular diseases. The company's lead product, SGT-001, is an investigational gene therapy for Duchenne muscular dystrophy (DMD). Solid Biosciences has a strong pipeline of gene therapies targeting rare diseases, with a focus on neuromuscular disorders.","hq":"Cambridge, MA","founded":0,"employees":"","ceo":"Ilan Ganot","sector":"Gene Therapy / Rare Disease","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"$900M","metrics":{"revenue":8094000,"revenueGrowth":-40.6,"grossMargin":0,"rdSpend":140325000,"netIncome":-117223000,"cash":232540000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2022"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2034-06-01","label":"SGT-001 patent cliff ($0.0B at risk)","drug":"SGT-001","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"SGT-003","genericName":"SGT-003","slug":"sgt-003","indication":"Duchenne muscular dystrophy","status":"phase_3"}]}],"pipeline":[{"name":"SGT-003","genericName":"SGT-003","slug":"sgt-003","phase":"phase_3","mechanism":"SGT-003 is a gene therapy that aims to deliver a functional dystrophin gene to muscle cells.","indications":["Duchenne muscular dystrophy"],"catalyst":""}],"recentEvents":[{"date":"2024-02-27","type":"regulatory","headline":"Solid Biosciences Announces FDA Clearance of Investigational New Drug (IND) Application for SGT-001","summary":"Solid Biosciences announced that the FDA has cleared the IND application for SGT-001, allowing the company to initiate a Phase 3 clinical trial for the treatment of DMD.","drugName":"SGT-001","sentiment":"positive"},{"date":"2023-11-07","type":"earnings","headline":"Solid Biosciences Reports Third Quarter 2023 Financial Results","summary":"Solid Biosciences reported its third quarter 2023 financial results, with a net loss of $23.4 million.","drugName":"","sentiment":"neutral"}],"realNews":[{"date":"2026-03-19","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPYmxESno1RlRfU3IzMlNYaDh3QTdJVXdIYk5rb0xlbWU5cFZvSWxjdEhpdE5BUERaVU9vTUt1eEI0ZXJUeUNmX2VTN29rTVdrdVZMWXVmZVdjcVlpT1g2MmlLVGpuQjV1Qlo5alJDcENXTEpfMnlOVWNLV3dCVWtlU2xVNXRMLTRYcFBEa2ljc1pRaVFsYU85YW5fRzhqcnI1MkZUZnQ1ZlNndUgtaVBvWngwdw?oc=5","date":"2026-03-12","type":"trial","source":"Seeking Alpha","summary":"Solid Biosciences: Interim Data Lends Credibility For Q1 2026 Trial Start (NASDAQ:SLDB) - Seeking Alpha","headline":"Solid Biosciences: Interim Data Lends Credibility For Q1 2026 Trial Start (NASDAQ:SLDB)","sentiment":"neutral"},{"date":"2026-03-12","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQbWJrNnNHelU0SXNOc2E1b3p6amhaY3hLSnhBQ3VNWndNa2VjQndJLWdybE5VTHZwMGN5ejhZSnYwTGtFUHBHcThDOE10NFZ6Z1V4YnpuaHdrZUlrOEd1U1dGUnhQOEJURjZOM0QwQjhIYVlpb3BvQ05rMTg1TDRFaF9fMmJlX1hIS1FIdGRmZ09Ia1Z3aVhSWTNXSDBSQ2Q5T3VaOW1vVmNQWHBxcC1BRm1RM1JpcWk5?oc=5","date":"2026-03-06","type":"pipeline","source":"Stock Titan","summary":"Genetic medicines maker Solid Biosciences raises $240M from Perceptive and Bain - Stock Titan","headline":"Genetic medicines maker Solid Biosciences raises $240M from Perceptive and Bain","sentiment":"neutral"},{"date":"2026-03-06","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-16","type":"pipeline","source":"simplywall.st","summary":"Solid Biosciences Insiders Sold US$823k Of Shares Suggesting Hesitancy - simplywall.st","headline":"Solid Biosciences Insiders Sold US$823k Of Shares Suggesting Hesitancy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPTTczM3h2QzRacGJUWlNYOE93UlN1VWNDMnhIRTA1WXVtNHVfSHFHNjBsU0xtMnhLdEFITnNHZWJhY3BVSlBUX0MzZ3JxbE9fX2c2eXdTNXhZZlpZekN6bkNVOXJNbmlVUWVHZkdvWDBQMWl5OHpNaURzVTRtemJIb3EzdC1GbE41eTh0aWc0enRSdDViNll4WU1jSXNuNmRFTnVuSUlHSzF5QTNpa1J1Nw?oc=5","date":"2026-02-09","type":"regulatory","source":"Seeking Alpha","summary":"Solid Biosciences: Positive FDA Meeting SGT-003 Sets Up Next Milestones (NASDAQ:SLDB) - Seeking Alpha","headline":"Solid Biosciences: Positive FDA Meeting SGT-003 Sets Up Next Milestones (NASDAQ:SLDB)","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-23","type":"pipeline","source":"simplywall.st","summary":"We're Keeping An Eye On Solid Biosciences' (NASDAQ:SLDB) Cash Burn Rate - simplywall.st","headline":"We're Keeping An Eye On Solid Biosciences' (NASDAQ:SLDB) Cash Burn Rate","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE5jblhvcEU2enJ2RTk0MzRKenU2SXY3dWExM0c3OUFWMVBnSk80RWpiNUZ5cTRfMzV2VmFKb3pyaTN6dnJUOXZDQkFhQk0ycXlkNTF1TldHWHc2d3NJN204S0VGVDFRUm5D?oc=5","date":"2025-07-09","type":"regulatory","source":"MarketBeat","summary":"Solid Biosciences (SLDB) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat","headline":"Solid Biosciences (SLDB) FDA Approvals, PDUFA Dates & Drug Alerts 2026","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxQSkJEd0tBT0hYbFRrdWJmMnRDQ184VEVkc3dBQUMwbjE5TGxYMEp1TC1DNU1yMlVwMUZXV3huM005VDZJaVZyNWEtR3dUZXFtblJqbnIwc05VVVZmVlh0T21aTE9LVVg0YXkwXzI0UFhRRHljLXRZdHlZYU5JQzFrNkRxVk5OTmJCYVZtODZmY1RBQXBqYmdBWTB6OA?oc=5","date":"2025-04-08","type":"pipeline","source":"MarketBeat","summary":"Can Solid Biosciences Challenge Sarepta in the DMD Market? - MarketBeat","headline":"Can Solid Biosciences Challenge Sarepta in the DMD Market?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTFBlOEQ1YmNfeHdzM3h1VkI3MHAySUlYQXEwX2swRTNvaWVhaDU5aTdVTkhCb0FXS2drbHlLcVBac1lHQ01oQXVKNFh5QjlnQ25q?oc=5","date":"2023-11-15","type":"pipeline","source":"CNN","summary":"symbol__ Stock Quote Price and Forecast - CNN","headline":"symbol__ Stock Quote Price and Forecast","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTFBRUXdTS2ZIaVNUZTRUWG1UbDJ5S0J5aDZsbnZyZ3dVb2Q4clBrMUtiN2hBZWhkR09UN05tczluSkhwdmRZZGxPbUVHVk1fTzFPbE9lTFV0TWxJd3pCN29aRFhqZGdsUG5MVmgxOHhka3NqWTQ3NFJv?oc=5","date":"2021-12-28","type":"pipeline","source":"Barron's","summary":"Here Are 8 Biotech Stocks That Trade for Less Than Their Cash - Barron's","headline":"Here Are 8 Biotech Stocks That Trade for Less Than Their Cash - Barron's","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQdHBFbWpmb3JwQnVVY2ItcEdLUzdpX2xpT2VzV21pNDVoUHNMazdmTzBuVFE2bFZ2MFpzWDExY2ZycndTZkN6U0J0X1hUWGxVMFNGQ3paNlZxOEFNUnd6VV9nNFJJQUtHbmxzYXpUaE4yRXhmOUtNUlJKR0h6OFB5blBRMnY0SlVMTjBhUW16Qm9qc2Zn?oc=5","date":"2019-11-12","type":"pipeline","source":"The Motley Fool","summary":"Here's Why Solid Biosciences Collapsed Today - The Motley Fool","headline":"Here's Why Solid Biosciences Collapsed Today","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1fdGJXOW5tUjl5bkZQaVVaMFFpQlRxaFhuLWUtMjBHVE1adzRKM2pPSElBTk0yTTBLS0ZOckZpZjFEUW5pSjk0SkR0SXBzWTZNeVFvajhWelVFajVYOVhV?oc=5","date":"2019-10-05","type":"pipeline","source":"ChartMill","summary":"SLDB Stock Price, Quote & Chart | SOLID BIOSCIENCES INC (NASDAQ:SLDB) - ChartMill","headline":"SLDB Stock Price, Quote & Chart | SOLID BIOSCIENCES INC (NASDAQ:SLDB)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBkd2l0VjlPWDJSUzhtWmRPeU9NaXRxal9LRlJ4d01fdUgyN1N5TFpJWVREdGJSaDk5RFBqN09ZNHB0VGpOZWU2UVE5dFlrdHh5Rklndkhhb3huMHQwSTRj?oc=5","date":"2018-02-10","type":"pipeline","source":"Zacks Investment Research","summary":"All News for SLDB : Solid Biosciences - Zacks Investment Research","headline":"All News for SLDB : Solid Biosciences","sentiment":"neutral"}],"patents":[{"drugName":"SGT-001","drugSlug":"generic","patentNumber":"","type":"Patent Cliff","expiryDate":"2034-06-01","territory":"US","annualRevenue":0}],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Sarepta Therapeutics","Pfizer","BioMarin Pharmaceutical"],"therapeuticFocus":["Gene Therapy","Rare Disease"],"financials":{"source":"sec_edgar+yahoo","revenue":8094000,"revenuePeriod":"2022-12-31","revenueHistory":[{"value":8094000,"period":"2022-12-31"},{"value":13620000,"period":"2021-12-31"},{"value":13620000,"period":"2021-12-31"},{"value":0,"period":"2020-12-31"},{"value":0,"period":"2020-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":140325000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-117223000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":232540000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}